Innovator’s Pitch Challenge

Interested in Connecting? Please contact:
B. Michael Silber
President and CEO
mbsilber@reileypharmaceuticals.com

Message the company or request a 1:1 meeting here

Reiley Pharmaceutical Inc. (RPI) is a precision medical company developing diagnostic imaging drugs, to illuminate the exact location of pain – most MDs are challenged because patients cannot precisely identify the source of their pain accurately. A selective COX-2 inhibitor is used to find the source of pain. It is combined with a Technetium 99m radioisotope to allow visualization of the real pathological (painful) target. These novel diagnostic agents, when injected into a patient as part of a lower back pain (LBP) diagnostic test, can localize to the region with overexpressed COX-2, bind to COX-2 enzymes and “light up” the cells, which enables standard hospital scanners to quickly and accurately identify and image the precise location of the pain source, solving the hardest challenge in LBP diagnostics.

Pitch Video

Slide Deck

Executive Summary